[
 {
    "Company": "InSphero",
    "Model": "3D InSight™ Human Liver Microtissues (Healthy or NASH)",
    "Organs/Tissues": "Liver spheroids (hepatocytes + NPCs ± stellate)",
    "Physiological/Pathological": "Both – normal or MASLD/MASH",
    "Cell Source": "Primary hepatocytes (pooled) + Kupffer + LEC ± stellates",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "Partial – optional stellates",
    "Tissue-resident Immune": "Yes (Kupffer)",
    "Circulating Immune": "No",
    "Crosstalk (Multi-tissue)": "No (single organ unless combined in OoC)",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "No scaffold, self-assembly",
    "3D Scaffold": "No external scaffold",
    "Notable Features": "Chronic DILI detection, NASH induction protocols",
    "Plate/Format (Throughput)": "Akura 96/384 plates, med–high",
    "Max Culture Duration": "4+ weeks",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Yes (endpoint)",
    "Readouts - Whole Tissue": "Yes",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Minimal well volume",
    "Perfused": "Static (manual media changes)",
    "Gas Mix Controlled": "Incubator (5% CO2)",
    "Real-time Microenvironment Control": "Automated dosing, imaging",
    "model_availability": "Both"
  },
  {
    "Company": "InSphero",
    "Model": "3D InSight™ Human Islet Microtissues",
    "Organs/Tissues": "Pancreatic pseudo-islets (β, α, δ)",
    "Physiological/Pathological": "Both – normal insulin response or diabetic stress",
    "Cell Source": "Primary islet cells re-aggregated",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "No",
    "Tissue-resident Immune": "No",
    "Circulating Immune": "No",
    "Crosstalk (Multi-tissue)": "No, single organ (can be combined if desired)",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "No scaffold, self-assembled",
    "3D Scaffold": "No",
    "Notable Features": "Stable glucose-stimulated insulin, 4+ weeks",
    "Plate/Format (Throughput)": "Akura 96/384, med–high",
    "Max Culture Duration": "≥4 weeks",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Yes (endpoint)",
    "Readouts - Whole Tissue": "Yes",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Low well volume",
    "Perfused": "Static",
    "Gas Mix Controlled": "Incubator",
    "Real-time Microenvironment Control": "Automated glucose ramps/imaging",
    "model_availability": "Both"
  },
  {
    "Company": "InSphero",
    "Model": "3D InSight™ Tumor Microtissues",
    "Organs/Tissues": "Solid tumor spheroids (cell line or PDX)",
    "Physiological/Pathological": "Pathological – tumor microenvironment",
    "Cell Source": "Cancer cells ± fibroblasts",
    "Multiple Cell Types": "Yes (tumor + CAFs if desired)",
    "Stromal Cells": "Yes (optional fibroblasts)",
    "Tissue-resident Immune": "No unless custom",
    "Circulating Immune": "No default",
    "Crosstalk (Multi-tissue)": "No single organ unless further linking",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Spheroid or optional collagen for invasion",
    "3D Scaffold": "No external scaffold typically",
    "Notable Features": "HTS-friendly 3D tumor, drug screening",
    "Plate/Format (Throughput)": "Akura 96/384, high throughput",
    "Max Culture Duration": "Days–weeks",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Yes (endpoint)",
    "Readouts - Whole Tissue": "Yes",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Low well volume",
    "Perfused": "Static",
    "Gas Mix Controlled": "Incubator",
    "Real-time Microenvironment Control": "Automated dosing, time-lapse",
    "model_availability": "Both"
  },
  {
    "Company": "InSphero",
    "Model": "3D InSight™ Immuno-Oncology (Tumor + Immune Cells)",
    "Organs/Tissues": "Tumor spheroid co-cultured with T/NK cells",
    "Physiological/Pathological": "Pathological tumor + immune infiltration",
    "Cell Source": "Tumor cells ± fibroblasts + T/NK cells, PBMC etc.",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "Yes if tumor has CAFs",
    "Tissue-resident Immune": "No, immune cells added externally",
    "Circulating Immune": "Yes (immune cells in co-culture)",
    "Crosstalk (Multi-tissue)": "No single tumor–immune model",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Spheroid-based, optional matrix",
    "3D Scaffold": "No typical scaffold",
    "Notable Features": "Immunotherapy screening, infiltration & killing measured",
    "Plate/Format (Throughput)": "Akura 96/384, moderate–high",
    "Max Culture Duration": "3–7 days typically",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Yes",
    "Readouts - Whole Tissue": "Yes",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Low",
    "Perfused": "Static (flow in dev)",
    "Gas Mix Controlled": "Incubator",
    "Real-time Microenvironment Control": "Time-lapse infiltration/killing",
    "model_availability": "Both"
  }
]